Literature DB >> 18217189

Sedative and anticonvulsant effects of zolpidem in adult and aged mice.

Danka Pericić1, Josipa Vlainić, Dubravka Svob Strac.   

Abstract

To evaluate the possible age-related differences in the behavioral effects of zolpidem, a widely used hypnotic, we compared the effects of zolpidem on the locomotor activity and on the seizure threshold for pentylenetetrazole (PTZ) and picrotoxin (given by i.v. infusion) between adult (3 months) and aged (13 months) mice. Zolpidem (10 mg/kg) produced similar enhancements of the seizure threshold in adult and aged mice. The drug was more potent against PTZ- than against picrotoxin-induced seizures. Diazepam (1 mg/kg), which was taken for comparison, had a weaker effect on picrotoxin-induced tonic seizures in aged than in adult mice. Sedative effect of zolpidem (10 mg/kg), as assessed by its effect on the locomotor activity, was very strong in both groups of mice. The results suggest that sedative and antiseizure effects of zolpidem are not changed in aged mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18217189     DOI: 10.1007/s00702-008-0020-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

1.  Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs.

Authors:  A E Kosobud; J C Crabbe
Journal:  Brain Res       Date:  1990-08-27       Impact factor: 3.252

2.  GABAA receptor subunit expression changes in the rat cerebellum and cerebral cortex during aging.

Authors:  A Gutiérrez; Z U Khan; C P Miralles; A K Mehta; D Ruano; F Araujo; J Vitorica; A L De Blas
Journal:  Brain Res Mol Brain Res       Date:  1997-04

3.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

Authors:  U Rudolph; F Crestani; D Benke; I Brünig; J A Benson; J M Fritschy; J R Martin; H Bluethmann; H Möhler
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

4.  New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.

Authors:  G Griebel; G Perrault; V Letang; P Granger; P Avenet; H Schoemaker; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1999-09       Impact factor: 4.530

Review 5.  Progression and generalization of seizure discharge: anatomical and neurochemical substrates.

Authors:  K Gale
Journal:  Epilepsia       Date:  1988       Impact factor: 5.864

6.  Absence of modifications of the pharmacological properties of the GABAA receptor complex during aging, as assessed in 3- and 24-month-old rat cerebral cortex.

Authors:  D Ruano; A Machado; J Vitorica
Journal:  Eur J Pharmacol       Date:  1993-06-15       Impact factor: 4.432

7.  Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.

Authors:  Joel O Olubodun; Hermann R Ochs; Lisa L von Moltke; Ronenn Roubenoff; Leah M Hesse; Jerold S Harmatz; Richard I Shader; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

8.  Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain.

Authors:  R F Squires; E Saederup; J N Crawley; P Skolnick; S M Paul
Journal:  Life Sci       Date:  1984-10-01       Impact factor: 5.037

9.  Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.

Authors:  G Perrault; E Morel; D J Sanger; B Zivkovic
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

10.  Evidence for central benzodiazepine receptor heterogeneity from behavior tests.

Authors:  M F Davies; E S Onaivi; S W Chen; P A Maguire; N F Tsai; G H Loew
Journal:  Pharmacol Biochem Behav       Date:  1994-09       Impact factor: 3.533

View more
  4 in total

Review 1.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

2.  The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant alpha1beta2gamma2s GABA(A) receptors expressed in HEK 293 cells.

Authors:  Josipa Vlainić; Maja Jazvinsćak Jembrek; Dubravka Svob Strac; Danka Pericić
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-23       Impact factor: 3.000

3.  Differential effects of short- and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABA(A) receptors in vitro.

Authors:  Josipa Vlainić; Maja Jazvinšćak Jembrek; Toni Vlainić; Dubravka Švob Strac; Danka Peričić
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

4.  Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope.

Authors:  Tamara Berdyyeva; Stephani Otte; Leah Aluisio; Yaniv Ziv; Laurie D Burns; Christine Dugovic; Sujin Yun; Kunal K Ghosh; Mark J Schnitzer; Timothy Lovenberg; Pascal Bonaventure
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.